NASDAQ Global Market • Financial Services • Asset Management • US • USD
Loncar Cancer Immunotherapy ETF (CNCR) has a market capitalization of $7.04M and trades at $9.02. The 52-week range is 7.881-16.27.
The stock has a beta of 0.96, operates in the Financial Services sector.
Be the first to know when stocks drop below their intrinsic value.
